Reclast Overdose: An Introduction
Reclast™ (
zoledronic acid) is a medication used to treat Paget's disease of the bone and
osteoporosis. It is given by IV (intravenously) and is part of a group of medications known as bisphosphonates. The specific effects of a Reclast overdose can vary depending on a number of factors, including the
Reclast dosage, how the drug was taken (by injection or by mouth), and whether it was taken with other medications or substances.
Symptoms of a Reclast Overdose
There have not been any cases of Reclast overdose reported, probably since the dose is given by a healthcare provider. Because of the way the medication works, the following overdose symptoms may be expected:
- Low blood calcium (hypocalcemia)
- Low blood magnesium (hypomagnesemia)
- Low blood phosphate (hypophosphatemia).
Treatment for a Reclast Overdose
The treatment for a Reclast overdose will also vary. Treatment may involve supportive care, which consists of treating the symptoms that occur as a result of the overdose. For example, supportive treatment options for a Reclast overdose may include:
- Careful monitoring of the heart, blood pressure, and breathing
- Fluids through an intravenous line (IV)
- Calcium, magnesium, or phosphate supplementation
- Other treatments based on complications that occur.
It is important that you seek medical attention immediately if you believe that you may have overdosed on Reclast.